| General Information | |||
|---|---|---|---|
| Term | lysinuric protein intolerance | ID (Ontology) | DOID:0060439 (Human Disease) |
| Definition | An amino acid metabolic disorder characterized by the body's inability to effectively break down lysine, arginine and ornithine and by renal hyperdiaminoaciduria, especially lysinuria, and by impaired formation of urea with hyperammonemia after protein ingestion. It has_material_basis_in homozygous or compound heterozygous mutation in the amino acid transporter gene SLC7A7 on chromosome 14q11. | ||
| Also Known As | "dibasic amino aciduria II" ; "hyperdibasic aminoaciduria" ; "LPI" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
inherited metabolic disorder |__amino acid metabolic disorder |__lysinuric protein intolerance 2 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | amino acid metabolic disorder | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:3335 MESH:C562687 MIM:222700 NCI:C121563 ORDO:470 SNOMEDCT_US_2023_03_01:13138006 UMLS_CUI:C0268647 |
|||